DARK SECRETS: 23 - The Real Truth

Pfizer doubling cost of Paxlovid

One of the most effective treatments for COVID is going to get a lot more expensive, but Pfizer insists it's fine

Salon · Oct 19, 2023

Why is Covid-19 Still Affecting the Healthcare Industry?

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

Barchart · Oct 18, 2023

Beyond COVID vaccines: what else could mRNA technology do for our health?

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

The Conversation · Oct 18, 2023

Chiefs’ Travis Kelce Responds to Aaron Rodgers’s ‘Mr. Pfizer’ Jab

“Who knew I’d get into the vax wars with Aaron Rodgers, man?”

Sports Illustrated · Oct 6, 2023

Updated COVID-19 shot slowly rolls out in Texas, but access is spotty

Doses aren’t arriving at providers’ offices at uniform, predictable intervals. Shipments are largely dependent on individual providers’ ability to work out the logistics of ordering, stocking, training and paperwork.

The Texas Tribune · Oct 5, 2023

Travis Kelce’s Rumored Romance With Taylor Swift Boosts Brand Engagement

Pfizer and Campbell Soup see surge in searches and sales after dating rumors

Zenger · Oct 5, 2023

Which Pharma Stock Has More Potential Gains This Month: Pfizer (PFE) or Eli Lilly & Co. (LLY)?

The pharmaceutical industry is poised for sustained long-term growth due to increased investments in drug development and rapid technological advancements. While leading pharma stocks Pfizer (PFE) and Eli Lilly (LLY) stand to benefit, let us analyze which of these giants is poised for more gains this month. Keep reading.

StockNews.com · Oct 5, 2023

Novavax COVID-19 vaccine approved

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

Salon · Oct 5, 2023

3 Quality Stocks to Defend Your Portfolio Against October Volatility

The sell-off in the U.S. stock market has deepened in October, and the Dow Jones Industrial Average is now negative for the year. Amid a challenging macro environment, Berkshire Hathaway, Pfizer, and Coca-Cola look like three good defensive stocks to buy.

Barchart · Oct 4, 2023

US adds another option for fall COVID vaccination with updated Novavax shots

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

The Independent UK · Oct 3, 2023